Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ZS
Valuation Bad
0%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio -12.52 1.67 1.90
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -80.07 -1.43 7.17
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value 12.99 7.27 6.44
Cash -9.75 14.90 16.51
Capex -20.73 -0.33 -0.28
Free Cash Flow 21.07 0.82 0.68
Revenue 4.43 3.68 3.52
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin 1.19 0.78 0.78
Operating Margin 91.08 < 0.005 -0.09
ROA -37.06 < 0.005 < 0.005
ROE -41.08 0.02 -0.03
ROIC 94.17 < 0.005 -0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ZS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ZS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ZS is permitted for members.